Janus Henderson Group’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.1M | Sell |
17,688,592
-5,046,529
| -22% | -$13.7M | 0.02% | 395 |
|
|
2025
Q1 | $52.4M | Buy |
22,735,121
+5,612,558
| +33% | +$12.9M | 0.03% | 368 |
|
|
2024
Q4 | $59.8M | Buy |
17,122,563
+4,776,697
| +39% | +$16.7M | 0.03% | 347 |
|
|
2024
Q3 | $50.9M | Buy |
12,345,866
+4,464,984
| +57% | +$18.4M | 0.03% | 384 |
|
|
2024
Q2 | $28.4M | Buy |
7,880,882
+2,760,309
| +54% | +$9.95M | 0.02% | 502 |
|
|
2024
Q1 | $16.9M | Buy |
+5,120,573
| New | +$16.9M | 0.01% | 587 |
|
|
2021
Q1 | – | Sell |
-1,124,678
| Closed | -$4M | – | 1604 |
|
|
2020
Q4 | $4M | Buy |
+1,124,678
| New | +$4M | ﹤0.01% | 1004 |
|